These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28780934)

  • 21. Noncoding RNAs in Cancer Cell Plasticity.
    Xu J; Liu S
    Adv Exp Med Biol; 2016; 927():173-89. PubMed ID: 27376735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
    Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
    Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
    Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
    Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
    Saitoh M
    Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX4 can redirect TGF-β-mediated SMAD3-transcriptional output in a context-dependent manner to promote tumorigenesis.
    Vervoort SJ; Lourenço AR; Tufegdzic Vidakovic A; Mocholi E; Sandoval JL; Rueda OM; Frederiks C; Pals C; Peeters JGC; Caldas C; Bruna A; Coffer PJ
    Nucleic Acids Res; 2018 Oct; 46(18):9578-9590. PubMed ID: 30137431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six family of homeobox genes and related mechanisms in tumorigenesis protocols.
    Armat M; Ramezani F; Molavi O; Sabzichi M; Samadi N
    Tumori; 2016 Jun; 2016(3):236-43. PubMed ID: 27056337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of EMT by STAT3 in gastrointestinal cancer (Review).
    Li B; Huang C
    Int J Oncol; 2017 Mar; 50(3):753-767. PubMed ID: 28098855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
    Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
    Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.
    Wang L; Li Y; Yang X; Yuan H; Li X; Qi M; Chang YW; Wang C; Fu W; Yang M; Zhang J; Han B
    Prostate; 2014 May; 74(6):647-58. PubMed ID: 24435928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance.
    Hashemi M; Hajimazdarany S; Mohan CD; Mohammadi M; Rezaei S; Olyaee Y; Goldoost Y; Ghorbani A; Mirmazloomi SR; Gholinia N; Kakavand A; Salimimoghadam S; Ertas YN; Rangappa KS; Taheriazam A; Entezari M
    Pharmacol Res; 2022 Dec; 186():106535. PubMed ID: 36334877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.
    Kaller M; Hermeking H
    Adv Exp Med Biol; 2016; 937():71-92. PubMed ID: 27573895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.
    Dhamija S; Diederichs S
    Int J Cancer; 2016 Jul; 139(2):269-80. PubMed ID: 26875870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
    Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ
    Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.